Haemonetics
HAE
#2913
Rank
NZ$10.18 B
Marketcap
NZ$223.76
Share price
1.60%
Change (1 day)
70.21%
Change (1 year)

EPS for Haemonetics (HAE)

EPS in 2026 (TTM): NZ$4.00

According to Haemonetics's latest financial reports the company's current EPS (TTM) is NZ$4.14. In 2025 the company made an earnings per share (EPS) of NZ$6.66 an increase over its 2024 EPS that were of NZ$4.67.

EPS history for Haemonetics from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$4.00-40.02%
2025NZ$6.6642.68%
2024NZ$4.672.43%
2023NZ$4.5633.73%
2022NZ$3.41332.49%
2021NZ$0.79
2018NZ$1.63-363.15%
2017NZ-$0.62-207.1%
2016NZ$0.58-132.28%
2015NZ-$1.79-269%
2014NZ$1.06-20%
2013NZ$1.32

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.17 193.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$7.43 79.41%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Thermo Fisher Scientific
TMO
NZ$34.59 735.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ-$2.57-162.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
NZ$6.56 58.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
NZ$17.21 315.54%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
NZ$14.02 238.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Cerus Corporation
CERS
NZ-$0.05464-101.32%๐Ÿ‡บ๐Ÿ‡ธ USA